Petros Pharmaceuticals, Inc. (PTPI) Operating margin 2020–2024
Petros Pharmaceuticals, Inc. (PTPI) operating margin by fiscal year — reported operating income divided by reported revenue.
-90.5%FY2024 · since FY2020: -180.8% → -90.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -90.5% | +143.4 pp |
| FY2023 | -233.9% | +98.5 pp |
| FY2022 | -332.4% | -101.3 pp |
| FY2021 | -231.1% | -50.3 pp |
| FY2020 | -180.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More PTPI financial trends
PTPI RevenuePTPI Net incomePTPI Net marginPTPI Gross profitPTPI Gross marginPTPI Operating incomePTPI Operating cash flowPTPI Free cash flowPTPI Capital expendituresPTPI Return on equityPTPI Stock buybacksPTPI Dividends paidPTPI Total assetsPTPI Total liabilitiesPTPI Shareholders’ equityPTPI overview →